South Dakota Investment Council’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-27,562
| Closed | -$782K | – | 643 |
|
|
2023
Q1 | $782K | Buy |
27,562
+887
| +3% | +$25.2K | 0.02% | 499 |
|
|
2022
Q4 | $780K | Buy |
26,675
+5,200
| +24% | +$152K | 0.02% | 489 |
|
|
2022
Q3 | $567K | Hold |
21,475
| – | – | 0.01% | 511 |
|
|
2022
Q2 | $954K | Sell |
21,475
-70,059
| -77% | -$3.11M | 0.02% | 449 |
|
|
2022
Q1 | $4.53M | Sell |
91,534
-21,000
| -19% | -$1.04M | 0.09% | 200 |
|
|
2021
Q4 | $5.73M | Buy |
112,534
+2,930
| +3% | +$149K | 0.1% | 191 |
|
|
2021
Q3 | $6.11M | Buy |
109,604
+54,010
| +97% | +$3.01M | 0.11% | 179 |
|
|
2021
Q2 | $2.38M | Buy |
+55,594
| New | +$2.38M | 0.04% | 312 |
|